These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23621659)

  • 1. How big is your hand and should you use it to score skin in cutaneous T-cell lymphoma?
    Scarisbrick JJ; Morris S
    Br J Dermatol; 2013 Aug; 169(2):260-5. PubMed ID: 23621659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas: the severity-weighted assessment tool (SWAT).
    Stevens SR; Ke MS; Parry EJ; Mark J; Cooper KD
    Arch Dermatol; 2002 Jan; 138(1):42-8. PubMed ID: 11790166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How big is a hand?
    Rossiter ND; Chapman P; Haywood IA
    Burns; 1996 May; 22(3):230-1. PubMed ID: 8726264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resuscitation burn card--a useful tool for burn injury assessment.
    Malic CC; Karoo RO; Austin O; Phipps A
    Burns; 2007 Mar; 33(2):195-9. PubMed ID: 17222978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
    Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
    J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified staging classification for cutaneous T-cell lymphoma.
    Kashani-Sabet M; McMillan A; Zackheim HS
    J Am Acad Dermatol; 2001 Nov; 45(5):700-6. PubMed ID: 11606919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
    Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani PL; Bernengo MG;
    Cancer; 2012 Dec; 118(23):5830-9. PubMed ID: 22674564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.
    Dalton SR; Chandler WM; Abuzeid M; Hossler EW; Ferringer T; Elston DM; LeBoit PE
    Am J Dermatopathol; 2012 Aug; 34(6):586-91. PubMed ID: 22814317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycosis fungoides palmaris et plantaris--an unusual variant of cutaneous T-cell lymphoma.
    Topf S; Lüftl M; Neisius U; Brabletz T; Simon M; Schuler G; Schultz ES
    Eur J Dermatol; 2006; 16(1):84-6. PubMed ID: 16436350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycosis fungoides: a dermatological masquerader.
    Nashan D; Faulhaber D; Ständer S; Luger TA; Stadler R
    Br J Dermatol; 2007 Jan; 156(1):1-10. PubMed ID: 17199560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma.
    Mann BS; Johnson JR; He K; Sridhara R; Abraham S; Booth BP; Verbois L; Morse DE; Jee JM; Pope S; Harapanhalli RS; Dagher R; Farrell A; Justice R; Pazdur R
    Clin Cancer Res; 2007 Apr; 13(8):2318-22. PubMed ID: 17438089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of burn size in obese adults; a literature review.
    Borhani-Khomani K; Partoft S; Holmgaard R
    J Plast Surg Hand Surg; 2017 Dec; 51(6):375-380. PubMed ID: 28417654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
    Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
    J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.
    Sugaya M; Hamada T; Kawai K; Yonekura K; Ohtsuka M; Shimauchi T; Tokura Y; Nozaki K; Izutsu K; Suzuki R; Setoyama M; Nagatani T; Koga H; Tani M; Iwatsuki K
    J Dermatol; 2013 Jan; 40(1):2-14. PubMed ID: 22900999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic criteria for early diagnosis of cutaneous T-cell lymphoma.
    Smith NP
    Dermatol Clin; 1994 Apr; 12(2):315-22. PubMed ID: 8045042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
    Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E
    Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased.
    Jacobson CC; Kimball AB
    Br J Dermatol; 2004 Aug; 151(2):381-7. PubMed ID: 15327545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.